- Home
- AMGN vs UNP Comparison
AMGN vs UNP Comparison
Compare AMGN & UNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMGN
- UNP
- Stock Information
- Founded
- AMGN 1980
- UNP 1862
- Country
- AMGN United States
- UNP United States
- Employees
- AMGN N/A
- UNP N/A
- Industry
- AMGN Biotechnology: Biological Products (No Diagnostic Substances)
- UNP Railroads
- Sector
- AMGN Health Care
- UNP Industrials
- Exchange
- AMGN Nasdaq
- UNP Nasdaq
- Market Cap
- AMGN 147.3B
- UNP 147.6B
- IPO Year
- AMGN N/A
- UNP N/A
- Fundamental
- Price
- AMGN $263.38
- UNP $226.25
- Analyst Decision
- AMGN Buy
- UNP Buy
- Analyst Count
- AMGN 22
- UNP 20
- Target Price
- AMGN $329.05
- UNP $259.80
- AVG Volume (30 Days)
- AMGN 4.7M
- UNP 2.9M
- Earning Date
- AMGN 02-04-2025
- UNP 01-23-2025
- Dividend Yield
- AMGN 3.62%
- UNP 2.37%
- EPS Growth
- AMGN N/A
- UNP 4.44
- EPS
- AMGN 7.83
- UNP 10.88
- Revenue
- AMGN $32,534,000,000.00
- UNP $24,288,000,000.00
- Revenue This Year
- AMGN $20.04
- UNP $1.53
- Revenue Next Year
- AMGN $3.41
- UNP $3.88
- P/E Ratio
- AMGN $33.62
- UNP $20.80
- Revenue Growth
- AMGN 21.25
- UNP 0.61
- 52 Week Low
- AMGN $253.30
- UNP $218.55
- 52 Week High
- AMGN $346.85
- UNP $258.66
- Technical
- Relative Strength Index (RSI)
- AMGN 31.29
- UNP 37.36
- Support Level
- AMGN $253.30
- UNP $231.89
- Resistance Level
- AMGN $280.00
- UNP $237.54
- Average True Range (ATR)
- AMGN 5.95
- UNP 4.41
- MACD
- AMGN -0.21
- UNP -1.29
- Stochastic Oscillator
- AMGN 35.90
- UNP 22.09
About AMGN Amgen Inc.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
About UNP Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the us, UP generated $24 billion of revenue in 2023 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, fertilizers, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.